Menu
GWAS Study

Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.

Ho JE, Chen WY, Chen MH et al.

23999434 PubMed ID
GWAS Study Type
2797 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HJ
Ho JE
CW
Chen WY
CM
Chen MH
LM
Larson MG
ME
McCabe EL
CS
Cheng S
GA
Ghorbani A
CE
Coglianese E
EV
Emilsson V
JA
Johnson AD
WS
Walter S
FN
Franceschini N
OC
O'Donnell CJ
DA
Dehghan A
LC
Lu C
LD
Levy D
NC
Newton-Cheh C
LH
Lin H
FJ
Felix JF
SE
Schreiter ER
VR
Vasan RS
JJ
Januzzi JL
LR
Lee RT
WT
Wang TJ
Chapter II

Abstract

Summary of the research findings

The suppression of tumorigenicity 2/IL-33 (ST2/IL-33) pathway has been implicated in several immune and inflammatory diseases. ST2 is produced as 2 isoforms. The membrane-bound isoform (ST2L) induces an immune response when bound to its ligand, IL-33. The other isoform is a soluble protein (sST2) that is thought to be a decoy receptor for IL-33 signaling. Elevated sST2 levels in serum are associated with an increased risk for cardiovascular disease. We investigated the determinants of sST2 plasma concentrations in 2,991 Framingham Offspring Cohort participants. While clinical and environmental factors explained some variation in sST2 levels, much of the variation in sST2 production was driven by genetic factors. In a genome-wide association study (GWAS), multiple SNPs within IL1RL1 (the gene encoding ST2) demonstrated associations with sST2 concentrations. Five missense variants of IL1RL1 correlated with higher sST2 levels in the GWAS and mapped to the intracellular domain of ST2, which is absent in sST2. In a cell culture model, IL1RL1 missense variants increased sST2 expression by inducing IL-33 expression and enhancing IL-33 responsiveness (via ST2L). Our data suggest that genetic variation in IL1RL1 can result in increased levels of sST2 and alter immune and inflammatory signaling through the ST2/IL-33 pathway.

2,797 individuals

Chapter III

Study Statistics

Key metrics and study information

2797
Total Participants
GWAS
Study Type
No
Replicated
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.